Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lentigen Technology

Lentigen Technology
2014 FOUNDED
M&A STATUS
51-60 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of Lentiviral vector technology platform. The company platform is used for delivering genetic material into cells to modulate their function.

Formerly Known As
Lentigen Corp
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Parent Company
Miltenyi Biotec
Primary Office
  • 910 Clopper Road
  • Suite 200 S
  • Gaithersburg, MD 20878
  • United States

+1 (301) 000-0000

Lentigen Technology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Lentigen Technology‘s full profile, request access.

Request full access to PitchBook

Lentigen Technology Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Lentigen Technology‘s full profile, request access.

Request full access to PitchBook

Lentigen Technology Executive Team (3)

Name Title Board
Seat
Contact
Info
Boro Dropulic Ph.D Chief Scientific Officer & General Manager
Lajos Baranyi Ph.D Director, Basic Research
Heather Embree Director, Operations